Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Pfizer

How Is Pfizer's Stock Performance Compared to Other Pharmaceuticals Stocks?

Pfizer has underperformed the pharmaceuticals industry over the past year, but analysts are moderately optimistic about the stock’s prospects.

Barchart

3 Gene Therapy Stocks With Game-Changing Potential

Gene therapy stocks are transforming healthcare with revolutionary treatments. Therefore, as this sector continues to evolve, investing in gene therapy stocks like Pfizer (PFE), Sanofi (SNY), and Novartis AG (NVS) could be beneficial. Read on….

StockNews.com

Pfizer Exec Booed During White House Appearance as Trump Calls Pharma Head 'Great Businessman'

President Donald Trump's introduction of a Pfizer executive at the White House Wednesday was met with a roar of boos from the crowd.

Latin Times

From analysis to the latest developments in health,
read the most diverse news in one place.

Pfizer CEO Booed At White House Event

President Trump's praise of Pfizer CEO at Black History Month event sparks mixed audience reactions due to company's Covid-19 vaccine controversy.

Top News

Is This Dividend Stock a Buy After Better-Than-Expected Q4 Results?

Upcoming clinical trial results will give investors a much better look into Pfizer’s operational health.

Barchart

Joe Montana On Brock Purdy's Future, Notre Dame, and 49ers' Window

Football legend Joe Montana joins SI's Claudette Montana, on behalf of Pfizer, to discuss Brock Purdy's future in San Francisco, Marcus Freeman and Notre Dame,

Sports Illustrated

Factcheck: Has Pfizer released the list of side effects caused due to COVID vaccines?

A post is doing rounds on social media claiming that vaccine maker Pfizer's COVID vaccines have side effects including few fatal ones. The posts have shared a report with the logo of the US House of Representatives with a link that is directed to the official website.

The Times of India

Read news from The Economist, FT, and more,
with one subscription

Pfizer's Super Bowl 2025 Ad Featuring Young Cancer Survivor Sparks Mixed Reactions

Pfizer's Super Bowl ad received mixed reactions on social media, but many criticized the pharma giant for saying it will "knock out" cancer amid concerns over its COVID-19 vaccine.

International Business Times

The faulty forecasts of pharma firm investors: Misguided cynics miss the promising prognosis for drugmakers Pfizer and Merck

Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.

Fortune

Robert F. Kennedy had dinner with Pfizer CEO as he prepares to become health secretary, report says

Pfizer CEO certain that Trump’s administration ‘will be very, very prudent with everything they try to do’

The Independent UK

Stock Index Futures Muted Ahead of U.S. JOLTs Report and Fed Speak, Alphabet Earnings on Tap

March S&P 500 E-Mini futures (ESH25) are down -0.01%, and March Nasdaq 100 E-Mini futures (NQH25) are up +0.08% this morning as investors awaited the latest reading on U.S. job openings, comments from Federal Reserve officials, and corporate earnings reports from heavyweight names.

Barchart

Stock Index Futures Slip on Trade War Concerns, U.S. JOLTs Report and Alphabet Earnings on Tap

March S&P 500 E-Mini futures (ESH25) are down -0.21%, and March Nasdaq 100 E-Mini futures (NQH25) are down -0.11% this morning as investors adopted a cautious stance after China retaliated to new U.S. tariffs.

Barchart

Option Volatility And Earnings Report For February 3 - 7

Last week was extremely busy on the earnings front, so this week is a little more sedate. That being said, we still have some big names due to report including Amazon, Alphabet, Walt Disney, Palantir Technologies, Advanced Micro Devices, Microstrategy, Uber Technologies and Pfizer.

Barchart

Major players in the anti-DEI movement: Here's who's pressuring Goldman Sachs, Pfizer, IBM, and other Fortune 500 companies to drop their policies

A guide to the people and activist organizations who paved the way for Donald Trump's attacks on diversity practices in corporate America.

Fortune

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

What has the UK Covid inquiry learned so far about vaccines and treatments?

In fourth part of the inquiry, questons were asked about vaccine trials, procurement and the UK’s preparedness for future pandemics

Barchart

Pfizer Stock Outlook: Is Wall Street Bullish or Bearish?

Despite Pfizer trailing behind the broader market over the past year, Wall Street analysts remain moderately bullish about the stock's potential.

The Guardian - US

RFK Jr’s shifting vaccines stance worries experts ahead of confirmation hearing

Anti-vaccine rhetoric has been a lucrative enterprise for RFK Jr – one he is now trying to distance himself from

Top News

Pfizer To Pay Million In Kickback Scheme Settlement

Pfizer settles million over kickbacks for Nurtec ODT prescriptions; whistleblower rewarded.

Get all your
news in one place.

100's of premium titles.
One news app.

The Conversation

People on Ozempic may have fewer heart attacks, strokes and addictions – but more nausea, vomiting and stomach pain

Ozempic and Wegovy are increasingly available in Australia and worldwide to treat type 2 diabetes and obesity.

Kiplinger

Qorvo Stock Pops After Starboard Takes a Stake in the Apple Supplier: What to Know

Qorvo stock is soaring Friday after activist investor Starboard Value disclosed a new stake in the Apple supplier. Here's what investors need to know.

Barchart

This Dividend Stock Has Plunged Ahead of Trump’s Inauguration. Here Are 3 Reasons Investors Should Still Buy It.

For savvy investors, Pfizer could be an undervalued stock to buy here.

International Business Times UK

'Pfizer Boob Job': Several UK Women Say Their Breasts 'Quadrupled In Size' After COVID Shots

UK women report significant breast enlargement after Pfizer COVID-19 vaccine. Possible link to rare condition PASH, but requires further research.

Barchart

What to Expect From Pfizer's Next Quarterly Earnings Report

Pfizer is poised to announce its fourth-quarter results next month, and analysts predict a significant growth in the company’s bottom-line figure.

MarketBeat

Unstoppable Yields: 3 Blue-Chip Stocks to Maximize Returns

Explore established industry leaders with impressive dividend yields that are demonstrating the potential for growth and continued performance in 2025.

Medical Daily

Teen's Breast Grew To Triple G-Cup Size After COVID Vaccinations: Researchers Call It 'Exceedingly Rare'

Researchers have identified the condition as Pseudoangiomatous stromal hyperplasia (PASH)-associated gigantomastia, an "exceedingly rare" condition linked to COVID-19 vaccination.

1 … 11 12 13 14

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations